ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape

Li, Wei; Hao, Yi; Zhang, Xingda; Xu, Shouping*; Pang, Da*哈尔滨医科大学
Molecular Cancer2022-9-7DOI: 10.1186/s12943-022-01652-3
12被引10阅读
引用收藏
分享

摘要

Immunotherapy, especially immune checkpoint inhibitors (ICIs), has revolutionized the treatment of many types of cancer, particularly advanced-stage cancers. Nevertheless, although a subset of patients experiences dramatic and long-term disease regression in response to ICIs, most patients do not benefit from these treatments. Some may even experience cancer progression. Immune escape by tumor cells may be a key reason for this low response rate. N-6-methyladenosine (m(6)A) is the most common type of RNA methylation and has been recognized as a critical regulator of tumors and the immune system. Therefore, m(6)A modification and related regulators are promising targets for improving the efficacy of tumor immunotherapy. However, the association between m(6)A modification and tumor immune escape (TIE) has not been comprehensively summarized. Therefore, this review summarizes the existing knowledge regarding m(6)A modifications involved in TIE and their potential mechanisms of action. Moreover, we provide an overview of currently available agents targeting m(6)A regulators that have been tested for their elevated effects on TIE. This review establishes the association between m(6)A modifications and TIE and provides new insights and strategies for maximizing the efficacy of immunotherapy by specifically targeting m(6)A modifications involved in TIE.

学科与关键词

关键词
N-6-methyladenosine (m(6)A)cancerTumorImmunotherapyTumor immune escape (TIE)
相关
加载中…
  • Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy
    Liu, Weiwei; Liu, Chaoqun; Wang, Hui; Xu, Lijun; Zhou, Jueyu; Li, Sihua; Cheng, Yu; Zhou, Rui*; Zhao, Liang*Computational and Structural Biotechnology Journal, 2022, 20: 5150-5161.被引 5
  • N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
    Wang, Gaofeng; Zeng, Dongqiang; Sweren, Evan; Miao, Yong; Chen, Ruosi; Chen, Junjun; Wang, Jin; Liao, Wangjun; Hu, Zhiqi; Kang, Sewon; Garza, Luis A.*Journal of Investigative Dermatology, 2023, 143(8).被引 1
  • N6-methyladenosine RNA modifications: a potential therapeutic target for AML
    Hu, Rong; Liao, Peiyun; Xu, Binyan; Qiu, Yingqi; Zhang, Honghao; Li, Yuhua*Annals of Hematology, 2023.
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Cancer
发表日期
2022-09-07
卷期
第 21 卷, 第 1 期
页码
176
DOI
10.1186/s12943-022-01652-3
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
Harbin Medical University Cancer Hospital [Nn102017-02]; National Natural Science Foundation of China [81972706, 82173235, 82072904, 81872149]; Outstanding Youth Project of Heilongjiang Provincial Natural Science Foundation [YQ2019H027]; Distinguished Young Scholars of Harbin Medical University Cancer Hospital [JCQN2018-03]; Yong Elite Training Foundation Grant of Harbin Medical University Cancer Hospital [JY2016-02]; Heilongjiang Health and Family Planning Commission Foundation [2019-056]

作者

  • L

    Li, Wei (第一作者)

    harbin med univ

  • H

    Hao, Yi

    harbin med univ

查看全部 5 位作者收起作者
  • Z

    Zhang, Xingda

    harbin med univ

  • X

    Xu, Shouping (通讯)

    harbin med univ

  • P

    Pang, Da (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417